Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TOP1 | P11387 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3391749 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL309466 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL13134752 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3392184 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL15459817 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL600061 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL1017001 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL2065096 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL22128527 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL307897 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 893 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107335-A1 | COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASES BY INHIBITING EFHD1 | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | WO | claimed |
| US-20250333730-A1 | SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF | SHANGHAI JUNSHI BIOSCIENCES CO LTD (CN) | 2025-10-30 | — | — | US | claimed |
| US-20250213698-A1 | BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2025-07-03 | — | — | US | claimed |
| EP-4573605-A1 | METHOD FOR PRODUCING A BATTERY ACTIVE MATERIAL AND PRODUCT THEREOF | Novonix Anode Materials LLC (US) | 2025-06-25 | — | — | EP | claimed |
| US-20250151767-A1 | METHOD FOR MANUFACTURING WATER JELLY USING FERMENTED VINEGAR | CJ CHEILJEDANG CORPORATION (KR) | 2025-05-15 | — | — | US | claimed |
| US-12290567-B2 | Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates | ARCTURUS THERAPEUTICS, INC. (US) | 2025-05-06 | — | — | US | claimed |
| WO-2025083657-A1 | LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2025-04-24 | — | — | WO | claimed |
| EP-4499830-A1 | BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | Hansoh Bio LLC (US) | 2025-02-05 | — | — | EP | claimed |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2025-01-30 | — | — | US | claimed |
| US-20240392289-A1 | LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS | Hepagene Therapeutics (HK) Limited (CN) | 2024-11-28 | — | — | US | claimed |
| US-20040142065-A1 | Method and composition for improving the health of young monogastric mammals | LAND O'LAKES FARMLAND FEED LLC | 2004-07-22 | — | — | US | claimed |
| EP-0859695-B1 | COMPATIBILIZER FOR CARBON DIOXIDE-BLOWN POLYOLEFINIC FOAMS | PACTIV PROTECTIVE PACKAGING IN (US) | 2003-02-26 | — | — | EP | claimed |
| US-6440447-B1 | FEEDING RUMINANTS SORBITOL | LAND O'LAKES, INC. | 2002-08-27 | — | — | US | claimed |
| JP-2002514981-A | — | — | 2002-05-21 | — | — | JP | claimed |
| EP-0859695-A4 | COMPTABILIZER FOR CARBON DIOXIDE-BLOWN POLYOLEFINIC FOAMS | TENNECO PROTECTIVE PACKAGING I (US) | 1999-02-03 | — | — | EP | claimed |
| EP-0859695-A1 | COMPTABILIZER FOR CARBON DIOXIDE-BLOWN POLYOLEFINIC FOAMS | Tenneco Protective Packaging Inc. (US) | 1998-08-26 | — | — | EP | claimed |
| WO-1998005484-A9 | COMPTABILIZER FOR CARBON DIOXIDE-BLOWN POLYOLEFINIC FOAMS | — | 1998-05-07 | — | — | WO | claimed |
| WO-1998005484-A1 | COMPTABILIZER FOR CARBON DIOXIDE-BLOWN POLYOLEFINIC FOAMS | TENNECO PROTECTIVE PACKAGING INC. (US) | 1998-02-12 | — | — | WO | claimed |
| US-5144024-A | Contains another polyol, noncrystallizing | PEPPER TAMMY (GB) | 1992-09-01 | — | — | US | claimed |
| US-4127676-A | SUGAR ALCOHOL | FARMOS-YHTYMA OY (FI) | 1978-11-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12290567-B2 | Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates | ASGR1, FCGR2A, FCGR3B | LMNA 3283/4885L3MBTL1 2140/4885TDP1 3353/4885 |
| US-20240392289-A1 | LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS | FCGR2A, ASGR1, APLNR | LMNA 1001/4885L3MBTL1 3055/4885TDP1 2294/4885 |
| US-20250333730-A1 | SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF | TEK, TIE1, PCSK9 | LMNA 1942/4885L3MBTL1 68/4885TDP1 3658/4885 |
| US-20250213698-A1 | BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | PAICS, ABCG2, FOLR1 | LMNA 1401/4885L3MBTL1 4680/4885TDP1 4352/4885 |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | PHOSPHO1, LIPA, SLC7A1 | LMNA 397/4885L3MBTL1 305/4885TDP1 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.